Translational Development Acquisition Corp. SEC filings TDAC
Translational Development Acquisition Corp. has 80 filings in SEC EDGAR's recent list, going back to Jun 13, 2022. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 27, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 425 | Filing | Oct 30, 2026 | — |
| 425 | Filing | Oct 8, 2026 | — |
| 425 | Filing | Sep 24, 2026 | — |
| 425 | Filing | Sep 14, 2026 | — |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 425 | Filing | Aug 3, 2026 | — |
| 425 | Filing | Jul 28, 2026 | — |
| 425 | Filing | Jul 27, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 27, 2026 | Jul 27, 2026 |
| 8-K |
Current report
Other events
|
Jul 8, 2026 | Jul 6, 2026 |
| 425 | Filing | Jun 29, 2026 | — |
| DEFA14A | Additional proxy material | Jun 23, 2026 | — |
| 425 | Filing | Jun 23, 2026 | — |
| 8-K |
Current report
Other events
|
Jun 23, 2026 | Jun 22, 2026 |
| 425 | Filing | Jun 23, 2026 | — |
| 425 | Filing | Jun 22, 2026 | — |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change, Shareholder vote results
|
Jun 18, 2026 | Jun 17, 2026 |
| 425 | Filing | Jun 15, 2026 | — |
| 8-K |
Current report
Unregistered share sale
|
Jun 12, 2026 | Jun 12, 2026 |
| 425 | Filing | Jun 10, 2026 | — |
| 425 | Filing | Jun 2, 2026 | — |
| DEFA14A | Additional proxy material | May 28, 2026 | — |
| DEF 14A | Proxy statement | May 27, 2026 | Jun 17, 2026 |
| 425 | Filing | May 27, 2026 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 27, 2026 | May 27, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-K/A | Amended annual report | May 11, 2026 | Dec 31, 2025 |
| 10-K/A | Amended annual report | May 6, 2026 | Dec 31, 2025 |
| PRE 14A | Preliminary proxy statement | May 1, 2026 | Jun 17, 2026 |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 8-K |
Current report
New debt, Other events
|
Aug 14, 2025 | Aug 8, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Other events
|
Feb 14, 2025 | Feb 14, 2025 |
| 8-K |
Current report
Other events
|
Dec 31, 2024 | Dec 24, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Other events
|
Dec 27, 2024 | Dec 20, 2024 |
| 424B4 | Prospectus | Dec 23, 2024 | — |
| EFFECT | Filing | Dec 20, 2024 | — |
| CERT | Filing | Dec 20, 2024 | — |
| 8-A12B | Form 8-a12b | Dec 19, 2024 | — |
| CORRESP | Letter to the SEC | Dec 19, 2024 | — |
| CORRESP | Letter to the SEC | Dec 19, 2024 | — |
| S-1/A | Amended registration statement | Dec 19, 2024 | — |
| S-1/A | Amended registration statement | Nov 20, 2024 | — |
| CORRESP | Letter to the SEC | Nov 19, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 5, 2024 | — |
| S-1 | Registration statement | Oct 22, 2024 | — |
| CORRESP | Letter to the SEC | Oct 21, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 8, 2024 | — |
| DRS/A | Filing | Sep 12, 2024 | — |
| DRS | Filing | Aug 30, 2024 | — |
| SEC STAFF ACTION | Filing | Sep 29, 2023 | — |
| S-1 | Registration statement | Aug 26, 2022 | — |
| DRS | Filing | Jun 13, 2022 | — |
Showing 56 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Blank Checks (SIC 6770)
- Listed as
- TDAC (Nasdaq), TDACU (Nasdaq), TDACW (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1926599
Other Blank Checks companies
- Drugs Made In America Acquisition II Corp. DMII
- EQV Ventures Acquisition Corp. II EVAC
- Bain Capital GSS Investment Corp. BCSS
- Cantor Equity Partners IV, Inc. CEPF
- Churchill Capital Corp XII CXII
- American Exceptionalism Acquisition Corp. A AEXA
- New America Acquisition I Corp. NWAX
- Ares Acquisition Corp III AAC
Source: SEC EDGAR filings. This is company-reported data, not investment advice.